Golodirsen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Golodirsen, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy [Phase 4]